PARMX
Price
$37.55
Change
-$0.06 (-0.16%)
Updated
May 22 closing price
Net Assets
2.53B
VIMSX
Price
$72.98
Change
-$0.10 (-0.14%)
Updated
May 22 closing price
Net Assets
175.12B
Interact to see
Advertisement

PARMX vs VIMSX

Header iconPARMX vs VIMSX Comparison
Open Charts PARMX vs VIMSXBanner chart's image
Parnassus Mid-Cap
Price$37.55
Change-$0.06 (-0.16%)
VolumeN/A
Net Assets2.53B
Vanguard Mid Cap Index Investor
Price$72.98
Change-$0.10 (-0.14%)
VolumeN/A
Net Assets175.12B
PARMX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PARMX vs. VIMSX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PARMX is a StrongBuy and VIMSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 175B vs. PARMX (2.53B). VIMSX pays higher dividends than PARMX: VIMSX (1.48) vs PARMX (0.19). PARMX was incepted earlier than VIMSX: PARMX (20 years) vs VIMSX (27 years). PARMX (0.95) is less costly to investors than VIMSX (0.17). PARMX is a more actively managed with annual turnover of: 43.55 vs. VIMSX (16.00). PARMX has a lower initial minimum investment than VIMSX: PARMX (2000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 8.19 vs. PARMX (-2.50). VIMSX return over 5 years is better than : 74.65 vs. PARMX (23.16).
PARMXVIMSXPARMX / VIMSX
Total Expense Ratio0.950.17559%
Annual Report Gross Expense Ratio0.950.17559%
Fund Existence20 years27 years-
Gain YTD0.5351.46037%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.53B175B1%
Annual Yield % from dividends0.191.4813%
Returns for 1 year-2.508.19-30%
Returns for 3 years3.4328.2312%
Returns for 5 years23.1674.6531%
Returns for 10 years41.46108.3638%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRGIX7.17N/A
N/A
DWS RREEF Global Real Estate Secc Inst
LMOPX31.60N/A
N/A
Patient Opportunity C
VSOYX42.21N/A
N/A
Victory Sycamore Small Company Opp Y
NWXQX15.76N/A
N/A
Nationwide Mid Cap Market Idx Instl Svc
MSDUX13.13N/A
N/A
Morgan Stanley Emerging Mkt ex China I